Ito M, Mori Y, Oiso Y, Saito H
First Department of Internal Medicine, Nagoya University School of Medicine, Japan.
J Clin Invest. 1991 Feb;87(2):725-8. doi: 10.1172/JCI115052.
To elucidate the molecular mechanism of familial central diabetes insipidus (FDI), we sequenced the arginine vasopressin-neurophysin II (AVP-NPII) gene in 2 patients belonging to a pedigree that is consistent with an autosomal dominant mode of inheritance. 10 patients with idiopathic central diabetes insipidus (IDI) and 5 normals were also studied. The AVP-NPII gene, locating on chromosome 20, consists of three exons that encode putative signal peptide, AVP, NPII, and glycoprotein. Using polymerase chain reaction, fragments including the promoter region and all coding regions were amplified from genomic DNA and subjected to direct sequencing. Sequences of 10 patients with IDI were identical with those of normals, while in 2 patients with FDI, a single base substitution was detected in one of two alleles of the AVP-NPII gene, indicating they were heterozygotes for this mutation. It was a G----A transition at nucleotide position 1859 in the second exon, resulting in a substitution of Gly for Ser at amino acid position 57 in the NPII moiety. It was speculated that the mutated AVP-NPII precursor or the mutated NPII molecule, through their conformational changes, might be responsible for AVP deficiency.
为阐明家族性中枢性尿崩症(FDI)的分子机制,我们对来自一个符合常染色体显性遗传模式家系的2例患者的精氨酸加压素-神经垂体素II(AVP-NPII)基因进行了测序。还研究了10例特发性中枢性尿崩症(IDI)患者和5名正常人。位于20号染色体上的AVP-NPII基因由三个外显子组成,这些外显子编码假定的信号肽、AVP、NPII和糖蛋白。使用聚合酶链反应,从基因组DNA中扩增出包括启动子区域和所有编码区域的片段,并进行直接测序。10例IDI患者的序列与正常人相同,而在2例FDI患者中,在AVP-NPII基因的两个等位基因之一中检测到一个单碱基替换,表明他们是该突变的杂合子。这是第二外显子中核苷酸位置1859处的G→A转换,导致NPII部分中第57位氨基酸处的甘氨酸被丝氨酸取代。推测突变的AVP-NPII前体或突变的NPII分子通过其构象变化可能是AVP缺乏的原因。